-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NcoNaAAJ5G+oubTbEb5adtAwKSMmEgGHImFYdhgJwstg4PeALYHCvbOtcesdSYLE k6ZriZE8zplIrLh2Cs0ijQ== 0000929638-09-001492.txt : 20091022 0000929638-09-001492.hdr.sgml : 20091022 20091022161630 ACCESSION NUMBER: 0000929638-09-001492 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091022 DATE AS OF CHANGE: 20091022 GROUP MEMBERS: BAM CAPITAL, LLC GROUP MEMBERS: BAM MANAGEMENT, LLC GROUP MEMBERS: HAL MINTZ GROUP MEMBERS: ROSS BERMAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PONIARD PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000755806 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911261311 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-40119 FILM NUMBER: 091132652 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 270 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 2062862501 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 FORMER COMPANY: FORMER CONFORMED NAME: NEORX CORP DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAM Opportunity Fund, L.P. CENTRAL INDEX KEY: 0001433768 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 44 WALL STREET STREET 2: SUITE 1603 CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 646-307-4503 MAIL ADDRESS: STREET 1: 44 WALL STREET STREET 2: SUITE 1603 CITY: NEW YORK STATE: NY ZIP: 10005 SC 13G 1 poniard_sch13g.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number:      3235-0145

Expires:      February 28, 2009

Estimated average burden

hours per response...       10.4

 

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

                                                                                     

Poniard Pharmaceuticals, Inc.

(Name of Issuer)

 

Common Stock, $0.02 par value

(Title of Class of Securities)

 

 

732449301

(CUSIP Number)

 

October 21, 2009

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o

Rule 13d-1(b)

 

x

Rule 13d-1(c)

 

o

Rule 13d-1(d)

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

1

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only)

BAM Opportunity Fund, L.P.

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)         o

 

(b)         o

3

SEC Use Only

4

Citizenship or Place of Organization.

Delaware, U.S.A.

Number

of Shares

Beneficially

Owned by

Each

Reporting

Person With

5  Sole Voting Power

0

6  Shared Voting Power

1,755,598

Refer to Item 4 below.

7  Sole Dispositive Power

0

8  Shared Dispositive Power

1,755,598

Refer to Item 4 below.

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,755,598

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

 

11

Percent of Class Represented by Amount in Row (9)

5.05%

 

12

Type of Reporting Person (See Instructions)

PN

 

 

 

1

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only)

BAM Capital, LLC

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)         o

 

(b)         o

3

SEC Use Only

4

Citizenship or Place of Organization.

Delaware, U.S.A.

Number

of Shares

Beneficially

Owned by

Each

Reporting

Person With

5  Sole Voting Power

0

6  Shared Voting Power

1,755,598

Refer to Item 4 below.

7  Sole Dispositive Power

0

8  Shared Dispositive Power

1,755,598

Refer to Item 4 below.

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,755,598

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

 

11

Percent of Class Represented by Amount in Row (9)

5.05%

 

12

Type of Reporting Person (See Instructions)

OO

 

 

 

1

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only)

BAM Management, LLC

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)         o

 

(b)         o

3

SEC Use Only

4

Citizenship or Place of Organization.

Delaware, U.S.A.

Number

of Shares

Beneficially

Owned by

Each

Reporting

Person With

5  Sole Voting Power

0

6  Shared Voting Power

1,755,598

Refer to Item 4 below.

7  Sole Dispositive Power

0

8  Shared Dispositive Power

1,755,598

Refer to Item 4 below.

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,755,598

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

 

11

Percent of Class Represented by Amount in Row (9)

5.05%

 

12

Type of Reporting Person (See Instructions)

OO

 

 

 

1

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only)

Ross Berman

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)         o

 

(b)         o

3

SEC Use Only

4

Citizenship or Place of Organization.

United States of America

Number

of Shares

Beneficially

Owned by

Each

Reporting

Person With

5  Sole Voting Power

0

6  Shared Voting Power

1,755,598

Refer to Item 4 below.

7  Sole Dispositive Power

0

8  Shared Dispositive Power

1,755,598

Refer to Item 4 below.

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,755,598

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

 

11

Percent of Class Represented by Amount in Row (9)

5.05%

 

12

Type of Reporting Person (See Instructions)

IN

 

 

 

1

Names of Reporting Persons.

I.R.S. Identification Nos. of above persons (entities only)

Hal Mintz

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)         o

 

(b)         o

3

SEC Use Only

4

Citizenship or Place of Organization.

United States of America

Number

of Shares

Beneficially

Owned by

Each

Reporting

Person With

5  Sole Voting Power

0

6  Shared Voting Power

1,755,598

Refer to Item 4 below.

7  Sole Dispositive Power

0

8  Shared Dispositive Power

1,755,598

Refer to Item 4 below.

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,755,598

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

 

11

Percent of Class Represented by Amount in Row (9)

5.05%

 

12

Type of Reporting Person (See Instructions)

IN

 

 

Item 1.

(a)

Name of Issuer

 

 

Poniard Pharmaceuticals, Inc.

 

(b)

Address of Issuer's Principal Executive Offices

 

 

7000 Shoreline Court, Suite 270, South San Francisco, CA 94080

 

Item 2.

(a)

Name of Person Filing

 

 

(i) BAM Opportunity Fund, L.P. (the "Partnership"), a Delaware limited partnership, with respect to shares of Common Stock (as defined in Item 2(d) below) directly owned by it.

(ii) BAM Capital, LLC (the "General Partner"), which serves as the general partner of the Partnership.

(iii) BAM Management, LLC (the "Investment Manager"), which serves as the investment manager to the Partnership.

(iv) Mr. Hal Mintz who serves as a managing member of both the General Partner and the Investment Manager.

(v) Mr. Ross Berman who serves as a managing member of both the General Partner and the Investment Manager.

 

(b)

Address of Principal Business Office or, if none, Residence

 

BAM Opportunity Fund, L.P., c/o BAM Capital, LLC
BAM Capital, LLC

BAM Management, LLC

44 Wall Street, Suite 1603

New York, NY 10005

 

Ross Berman

Hal Mintz
c/o BAM Capital, LLC

44 Wall Street, Suite 1603

New York, NY 10005

 

(c)

Citizenship

 

BAM Opportunity Fund, L.P. - Delaware, U.S.A.
BAM Capital, LLC - Delaware, U.S.A.

BAM Management, LLC - Delaware, U.S.A.

 

Ross Berman - U.S.A.

Hal Mintz - U.S.A.

 

(d)

Title of Class of Securities

 

Common Stock, $0.02 par value (the "Common Stock")

 

(e)

CUSIP Number

 

 

732449301

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

o

Insurance Company as defined in Section 3(a)(19) of the Act

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

o

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

o

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

o

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

As of October 21, 2009, the Partnership held 168,698 shares of Common Stock of the Issuer and options to purchase 1,586,900 shares of Common Stock of the Issuer.

 

The percentages herein are calculated based upon 34,778,036 shares of Common Stock issued and outstanding as of August 18, 2009, as reported in the Issuer's prospectus dated August 19, 2009.

 

A. BAM Opportunity Fund, L.P.

 

(a) Amount beneficially owned: 1,755,598

 

(b) Percent of class: 5.05%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: -

 

(ii) Shared power to vote or direct the vote: 1,755,598

 

(iii) Sole power to dispose or direct the disposition:-

 

(iv) Shared power to dispose or direct the disposition: 1,755,598

 

 

B. BAM Capital, LLC

 

(a) Amount beneficially owned: 1,755,598

 

(b) Percent of class: 5.05%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: -

 

(ii) Shared power to vote or direct the vote: 1,755,598

 

(iii) Sole power to dispose or direct the disposition:-

 

(iv) Shared power to dispose or direct the disposition: 1,755,598

 

C. BAM Management, LLC

 

(a) Amount beneficially owned: 1,755,598

 

(b) Percent of class: 5.05%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: -

 

(ii) Shared power to vote or direct the vote: 1,755,598

 

(iii) Sole power to dispose or direct the disposition:-

 

(iv) Shared power to dispose or direct the disposition: 1,755,598

 

D. Hal Mintz

 

(a) Amount beneficially owned: 1,755,598

 

(b) Percent of class: 5.05%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: -

 

(ii) Shared power to vote or direct the vote: 1,755,598

 

(iii) Sole power to dispose or direct the disposition:-

 

(iv) Shared power to dispose or direct the disposition: 1,755,598

 

E. Ross Berman

 

(a) Amount beneficially owned: 1,755,598

 

(b) Percent of class: 5.05%

 

(c) Number of shares as to which such person has:

 

(i) Sole power to vote or direct the vote: -

 

(ii) Shared power to vote or direct the vote: 1,755,598

 

(iii) Sole power to dispose or direct the disposition:-

 

(iv) Shared power to dispose or direct the disposition: 1,755,598

 

This statement relates to Common Stock held by the Partnership over which the General Partner and the Investment Manager have discretionary trading authority. The managing members of the General Partner and the Investment Manager are Ross Berman and Hal Mintz, who share investment management duties. The Partnership, the General Partner, the Investment Manager, Mr. Mintz and Mr. Berman are hereinafter sometimes collectively referred to as the "Reporting Persons."

 

Each of the Reporting Persons disclaims beneficial ownership of all shares of Common Stock reported hereby, except to the extent of such Reporting Person's pecuniary interest therein.

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following

o.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

The Partnership is a private investment partnership, the sole general partner of which is the General Partner. As the sole general partner of the Partnership, the General Partner has the power to vote and dispose of the Common Stock owned by the Partnership and, accordingly, may be deemed the "beneficial owner" of such Common Stock. As the investment manager of the Partnership, the Investment Manager has the power to vote and dispose of the Common Stock owned by the Partnership and, accordingly, may be deemed the "beneficial owner" of such Common Stock. The managing members of the General Partner and the Investment Manager are Hal Mintz and Ross Berman.

 

 

Messrs. Mintz and Berman share investment management duties.

 

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group

Not applicable.

 

Item 9.

Notice of Dissolution of Group

Not applicable.

 

Item 10.

Certification

Each of the Reporting Persons hereby makes the following certification:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

 

October 22, 2009

 

 

 

BAM Opportunity Fund, L.P.

 

By: BAM Capital, LLC
its General Partner

 

By: /s/ Ross Berman  

Name: Ross Berman

Title: Managing Member

 

 

BAM Capital, LLC

 

By: /s/ Ross Berman  

Name: Ross Berman

Title: Managing Member

 

 

BAM Management, LLC

 

By: /s/ Ross Berman  

Name: Ross Berman

Title: Managing Member

 

 

/s/ Ross Berman  

Ross Berman

 

 

/s/ Hal Mintz  

Hal Mintz

 

 

Exhibit 1

JOINT FILING AGREEMENT

This Joint Filing Agreement, dated as of October 22, 2009, is entered into by and among BAM Capital, LLC, a Delaware limited liability company, BAM Management, LLC, a Delaware limited liability company, BAM Opportunity Fund, L.P., a Delaware limited partnership, Ross Berman, an individual, and Hal Mintz, an individual (all of the foregoing are collectively referred to herein as the "BAM Entities").

Each of the BAM Entities may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G (and amendments thereto) with respect to shares of common stock, par value $0.02 per share, of Poniard Pharmaceuticals, Inc., a Washington corporation, beneficially owned by them from time to time.

Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the parties hereby agree to file a single statement on Schedule 13G (and any amendments thereto) on behalf of each of the parties, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.

This Joint Filing Agreement may be terminated by any of the BAM Entities upon one week's prior written notice or such lesser period of notice as the BAM Entities may mutually agree.

 

Executed and delivered as of the date first above written.

 

BAM Opportunity Fund, L.P.

 

By: BAM Capital, LLC, its General Partner

 

By: /s/ Ross Berman

 

Name: Ross Berman

 

Title:  Managing Member

 

 

BAM Capital, LLC

 

By: /s/ Ross Berman

 

Name: Ross Berman

 

Title: Managing Member

 

BAM Management, LLC

 

By: /s/ Ross Berman

 

Name: Ross Berman

 

Title: Managing Member

 

/s/ Ross Berman

Ross Berman

 

/s/ Hal Mintz

Hal Mintz

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----